Literature DB >> 16339353

Expression of UDP-glucuronosyltransferase isoform mRNAs during inflammation and infection in mouse liver and kidney.

Terrilyn A Richardson1, Melanie Sherman, Daniel Kalman, Edward T Morgan.   

Abstract

Inflammation or infection down-regulates the activity and expression of cytochrome P450 (P450) enzymes involved in hepatic drug clearance, possibly altering drug effectiveness and leading to toxicity. The regulation of UDP-glucuronosyltransferases (UGTs) in inflammation and infection is less well characterized. To determine the response of hepatic and renal UGTs during inflammation and infection, mice were administered either saline or 1 mg/kg lipopolysaccharide (LPS) (16 h), or Citrobacter rodentium by oral gavage (6 days). Hepatic mRNA expression of UGT1A1, 1A9, and 2B5 was similarly down-regulated after LPS exposure and C. rodentium infection, whereas UGT1A2 and 1A6 mRNAs were unchanged. Effects of C. rodentium infection did not require a functional Toll-like receptor 4. Conversely, renal UGT isoforms were relatively unaffected, except for UGT2B5 induction after LPS treatment. Regulation of UGTs during the inflammatory response exhibits similarities to and differences from regulation of P450s, and may be cytokine-mediated.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16339353      PMCID: PMC1403152          DOI: 10.1124/dmd.105.007435

Source DB:  PubMed          Journal:  Drug Metab Dispos        ISSN: 0090-9556            Impact factor:   3.922


  18 in total

1.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

2.  Modulation of cytochrome P-450 gene expression in endotoxemic mice is tissue specific and peroxisome proliferator-activated receptor-alpha dependent.

Authors:  T B Barclay; J M Peters; M B Sewer; L Ferrari; F J Gonzalez; E T Morgan
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

3.  Regulation of uridine diphosphate glucuronosyltransferase during the acute-phase response.

Authors:  S I Strasser; M L Mashford; P V Desmond
Journal:  J Gastroenterol Hepatol       Date:  1998-01       Impact factor: 4.029

4.  Endotoxin inhibits glucuronidation in the liver. An effect mediated by intercellular communication.

Authors:  G Bánhegyi; I Mucha; T Garzó; F Antoni; J Mandl
Journal:  Biochem Pharmacol       Date:  1995-01-06       Impact factor: 5.858

5.  Hepatic cytochrome P450 gene regulation during endotoxin-induced inflammation in nuclear receptor knockout mice.

Authors:  Terrilyn A Richardson; Edward T Morgan
Journal:  J Pharmacol Exp Ther       Date:  2005-04-28       Impact factor: 4.030

6.  Hepatic and renal cytochrome p450 gene regulation during citrobacter rodentium infection in wild-type and toll-like receptor 4 mutant mice.

Authors:  Terrilyn A Richardson; Melanie Sherman; Leposava Antonovic; Sean S Kardar; Henry W Strobel; Daniel Kalman; Edward T Morgan
Journal:  Drug Metab Dispos       Date:  2005-12-08       Impact factor: 3.922

7.  Effects of interleukin-6 on cytochrome P450-dependent mixed-function oxidases in the rat.

Authors:  Y L Chen; I Florentin; A M Batt; L Ferrari; J P Giroud; L Chauvelot-Moachon
Journal:  Biochem Pharmacol       Date:  1992-07-07       Impact factor: 5.858

8.  Differential inductive and suppressive effects of endotoxin and particulate irritants on hepatic and renal cytochrome P-450 expression.

Authors:  M B Sewer; D R Koop; E T Morgan
Journal:  J Pharmacol Exp Ther       Date:  1997-03       Impact factor: 4.030

Review 9.  Cytochrome P450 regulation and drug biotransformation during inflammation and infection.

Authors:  Kenneth W Renton
Journal:  Curr Drug Metab       Date:  2004-06       Impact factor: 3.731

Review 10.  Attaching-effacing bacteria in animals.

Authors:  A D Wales; M J Woodward; G R Pearson
Journal:  J Comp Pathol       Date:  2005-01       Impact factor: 1.311

View more
  18 in total

1.  Acute liver failure enhances oral plasma exposure of zidovudine in rats by downregulation of hepatic UGT2B7 and intestinal P-gp.

Authors:  Fan Wang; Ming-Xing Miao; Bin-Bin Sun; Zhong-Jian Wang; Xian-Ge Tang; Yang Chen; Kai-Jing Zhao; Xiao-Dong Liu; Li Liu
Journal:  Acta Pharmacol Sin       Date:  2017-08-03       Impact factor: 6.150

2.  Chlorpromazine-induced hepatotoxicity during inflammation is mediated by TIRAP-dependent signaling pathway in mice.

Authors:  Adarsh Gandhi; Tao Guo; Pranav Shah; Bhagavatula Moorthy; Romi Ghose
Journal:  Toxicol Appl Pharmacol       Date:  2012-12-11       Impact factor: 4.219

Review 3.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Authors:  Yan Guo; Bingfang Hu; Yang Xie; Timothy R Billiar; Jason L Sperry; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-01-28       Impact factor: 4.481

4.  CYP3A-dependent drug metabolism is reduced in bacterial inflammation in mice.

Authors:  A S Gandhi; T Guo; P Shah; B Moorthy; D S-L Chow; M Hu; R Ghose
Journal:  Br J Pharmacol       Date:  2012-08       Impact factor: 8.739

5.  Upregulation of Ugt1a genes in placentas and fetal livers in a murine model of assisted reproduction.

Authors:  A C Collier; K A Milam; L R A Rougée; A Sugawara; Y Yamauchi; M A Ward
Journal:  Placenta       Date:  2011-11-25       Impact factor: 3.481

6.  Differences in the disposition of silymarin between patients with nonalcoholic fatty liver disease and chronic hepatitis C.

Authors:  Sarah J Schrieber; Roy L Hawke; Zhiming Wen; Philip C Smith; K Rajender Reddy; Abdus S Wahed; Steven H Belle; Nezam H Afdhal; Victor J Navarro; Catherine M Meyers; Edward Doo; Michael W Fried
Journal:  Drug Metab Dispos       Date:  2011-08-24       Impact factor: 3.922

7.  Contributions of Hepatic and Intestinal Metabolism to the Disposition of Niclosamide, a Repurposed Drug with Poor Bioavailability.

Authors:  Xiaoyu Fan; Hongmin Li; Xinxin Ding; Qing-Yu Zhang
Journal:  Drug Metab Dispos       Date:  2019-04-30       Impact factor: 3.922

Review 8.  Pharmacokinetics and Dosing of Anti-infective Drugs in Patients on Extracorporeal Membrane Oxygenation: A Review of the Current Literature.

Authors:  Jennifer Sherwin; Travis Heath; Kevin Watt
Journal:  Clin Ther       Date:  2016-08-21       Impact factor: 3.393

9.  Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.

Authors:  Yoshiaki Kimura; Mika Shibata; Mika Tamada; Noriyuki Ozaki; Kunizo Arai
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

Review 10.  Pharmacology of morphine in obese patients: clinical implications.

Authors:  Célia Lloret Linares; Xavier Declèves; Jean Michel Oppert; Arnaud Basdevant; Karine Clement; Christophe Bardin; Jean Michel Scherrmann; Jean Pierre Lepine; Jean François Bergmann; Stéphane Mouly
Journal:  Clin Pharmacokinet       Date:  2009       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.